Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Randomized Multicenter Study to Evaluate the Efficacy of Early Administration of Tocilizumab (TCZ) in Patients With COVID-19 Pneumonia

NCT04346355 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT04346355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04346355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Randomized Multicenter Study to Evaluate the Efficacy of Early Administration of Tocilizumab (TCZ) in Patients With COVID-19 Pneumonia
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2020
Completion date
June 6, 2020
Enrollment
126 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia